?:authorAffiliation
|
-
[\'Biochemistry of Chronic Diseases Laboratory, National Institute of Genomic Medicine, INMEGEN, Mexico City, Mexico.\', \'Computational Genomics Department, National Institute of Genomic Medicine, INMEGEN, Mexico City, Mexico.\', \'Cancer Genomics Laboratory, National Institute of Genomic Medicine, INMEGEN, Mexico City, Mexico.\', \'Cátedras CONACYT Program for Young Researchers, National Council for Science and Technology, CONACYT, México City, México.\', \'Center for Complexity Sciences (C3), National Autonomous University of Mexico, Mexico City, Mexico.\', \'Research Unit in Immunology and Proteomics, COVID-19 Research Laboratory, Children\'s Hospital of Mexico \'Federico Gómez\', Mexico City, Mexico.\', \'National Institute of Genomic Medicine, INMEGEN, Periférico Sur 4809, Arenal Tepepan, Tlalpan, 14610, Mexico City, Mexico.\', \'Innovation and Research Department, Salud Digna, Culiacan, Sinaloa, Mexico.\', \'Sequencing Unit, National Institute of Genomic Medicine, INMEGEN, Mexico City, Mexico.\', \'National Institute of Genomic Medicine, INMEGEN, Periférico Sur 4809, Arenal Tepepan, Tlalpan, 14610, Mexico City, Mexico. lherrera@inmegen.gob.mx.\', \'Biomedical Research Unit in Cancer, National Institute of Cancerology, Mexico City, Mexico. lherrera@inmegen.gob.mx.\', \'Institute of Biomedical Research, National Autonomous University of Mexico, Mexico City, Mexico. lherrera@inmegen.gob.mx.\', \'Unidad de Vinculación de la Facultad de Medicina, UNAM en el INMEGEN, Periférico Sur 4809, Arenal Tepepan, Tlalpan, 14610, Mexico City, Mexico. fvadillo@inmegen.gob.mx.\']
|